Yuyu Pharma Will Export SD BIOSENSOR COVID-19 Test Kits to the Global Market

Press Releases »

Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-Keun, Lee) entered into a Supply Agreement, where Yuyu Pharma will export COVID-19 Test Kits to the Global Market. Leveraging Yuyu Pharma's global network, the company is in talks with several healthcare providers and leading hospitals to export the COVID-19 kits.

Yuyu Pharma Will Export SD BIOSENSOR COVID-19 Test Kits to the Global Market

US FDA gave Emergency Use Authorization (EUA) to STANDARD M nCoV Real-Time Detection Kit made by SD BIOSENSOR back in April 23, 2020. With the EUA, SD BIOSENSOR has the authority to supply STANDARD M nCoV Real-Time Detection Kit across the US. STANDARD M nCoV Real-Time Detection Kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. This is RT-PCR test that amplifies and diagnoses a specific gene sequence of COVID-19. Yuyu Pharma Will Export SD BIOSENSOR COVID-19 Test Kits to the Global Market

Federal Emergency Management Agency (FEMA), an agency within the US Department of Homeland Security, has already purchased $5.2 million USD of SD Biosensor's test kits back in April 2020.

Hyo-Keun, Lee CEO of SD BIOSENSOR said that "We have been providing quality kits since 2010. Our HIV, Malaria and Syphilis test kits are already on the World Health Organization (WHO) list of prequalified in vitro diagnostic products. And we are proud to know that our COVID-19 kits will help facilitate in the fight against the spread of the coronavirus and possibly save lives. We will continue to provide quality products to help improve the health of all people around the world"

Robert Yu, CEO of Yuyu Pharma, said that "The partnership with SD BIOSENSOR will help provide much needed COVID-19 Kits to medical professionals. We hope our efforts will contribute in the fight against the coronavirus."

About Yuyu Pharma

Yuyu Pharma (KRX: 000220) is a pharmaceutical company founded in 1941. The company manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.

Yuyu pharma contact Point
Global Sales Team
Franklin Park / [email protected]

Photo - https://photos.prnasia.com/prnh/20200617/2833596-1-a
Caption - STANDARD(TM) M nCoV Real-Time Detection kit

Photo - https://photos.prnasia.com/prnh/20200617/2833596-1-b
Caption - Yuyu Pharma Will Export COVID-19 Test Kits to the Global Market


ข่าวthe company+Yuyu Pharmaวันนี้

Kaspersky launches Partnerverse - an interactive digital universe celebrating its global partner ecosystem

Kaspersky has announced the launch of Partnerverse, an interactive portal designed to showcase the company's global partner network across diverse regions and categories as well as highlight the vital role of partners in building a secure digital future. Kaspersky is a global, partner-driven cybersecurity leader dedicated to protecting businesses and consumers from evolving digital threats. Throughout its nearly three-decade history, the company has built an extensive global network of over 18

J&T Express, a leading global logistics s... J&T Express Receives Royal Plaque in Recognition of Its Support for World Heart Day Fun Run 2026 — J&T Express, a leading global logistics service pro...

Hisense, a leading brand in global consum... Hisense Unveils AI-Powered Growth Strategy to Shape the Next Era of Intelligent Living — Hisense, a leading brand in global consumer electronics and home ...

Bangkok, July 16, 2026: Bangkok Land Publ... BLAND announces dividend of 0.0125 baht per share at its 54th annual general meeting of shareholders — Bangkok, July 16, 2026: Bangkok Land Public Company...

MR. D.I.Y. Holding (Thailand) Public Comp... MR. D.I.Y. Wins "Marketeer No. 1 Brand Thailand 2026" for the Fourth Consecutive Year — MR. D.I.Y. Holding (Thailand) Public Company Limited, Thailand's l...

Bangkok: AstraZeneca (Thailand) Ltd., a l... AstraZeneca Thailand appoints John Serry as Country President — Bangkok: AstraZeneca (Thailand) Ltd., a leading global biopharmaceutical company, today an...